For the subgroup of 41 patients who did not present thyroid nodules, 12 (29%) patients were carriers of the MSH6 mutation, 17 (41%) of MSH2, 11 (27%) of MLH1, and 1 (3%) of PMS2. Here, PMS2 is linked to thyroid nodule.